DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "European Market Report for Endometrial Ablation Devices 2016 - MedCore" report to their offering.
The endometrial ablation market has experienced consistent growth from 2012 to 2016. The modest growth can be attributed to downward pressure on ASP due to past competition in the market. Endometrial ablation procedures are expected to continue to increase, as the European market is still actively growing and has yet to reach saturation. Medical professionals are further fueling the growth of endometrial ablation procedures. In the past the surgery performed to treat menorrhagia (heavy menstrual bleeding) has favored endometrial resection over endometrial ablation. Recently, this trend has started to reverse and endometrial ablation is gaining traction in procedure numbers, eroding the number of endometrial resection procedures being performed annually.
Global endometrial ablation (GEA) is a minimally invasive surgical procedure that can remove some or all of the lining of the uterus. It is performed on women who experience abnormal or extremely heavy bleeding, also known as menorrhagia. GEA requires less training for practitioners than the earlier forms of ablation, enabling more doctors to perform the procedure and making it more accessible to patients. The first GEA products were available on the market in 1997. The other types became available mostly between 2001 and 2002. There are a number of methods by which GEA can be performed: uterine balloon, heated fluid, high-frequency radio wave, cryoablation, microwave or roller-ball.
Key Topics Covered:
- Competitive Analysis
- Market Trends
- Market Developments
- Procedure Numbers
- Markets Included
- Key Report Updates
-
Version History
1. Research Methodology
2. Country Profiles
3. Endometrial Ablation Device Market
Companies Mentioned
- Bayer
- Karl Storz
- Cooper Surgical
- Olympus
- Richard Wolf
- Cook Medical
- Johnson & Johnson
- Astora Women's Health
- Vitrolife
- Boston Scientific
- Johnson & Johnson
- Hologic
For more information about this report visit http://www.researchandmarkets.com/research/4xppfm/european_market
